Required fields are marked with *

Verification code

Fialuridine

{PARAM:[Name]}()
Category Orthopoxvirus
CAS 69123-98-4
Description Fialuridine (FIAU) is a thymidine-based nucleoside analog with antiviral activity. Fialuridine and its metabolites blocks DNA synthesis in human cytomegalovirus and hepatitis B, as well as herpes simplex.
Quotation Now

Product Information

Synonyms 5-Iodo-2'-deoxy-2'-fluoro-beta-D-arabinouridine; FIAU; Fluoroiodoarauracil; 5-Iodo-2'-Fluoroarauracil; NSC 678514; 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodo-2,4(1H,3H)-pyrimidinedione; 1-(2'-Deoxy-2'-fluoro-β-D-arabinofuranosyl)-5-iodouracil
IUPAC Name 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione
Molecular Weight 372.09
Molecular Formula C9H10FIN2O5
Canonical SMILES C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I
InChI InChI=1S/C9H10FIN2O5/c10-5-6(15)4(2-14)18-8(5)13-1-3(11)7(16)12-9(13)17/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5+,6-,8-/m1/s1
InChIKey IPVFGAYTKQKGBM-BYPJNBLXSA-N
Melting Point 216-217 °C
Purity ≥95%
Density 2.18±0.1 g/cm3 (Predicted)
Solubility Soluble in DMSO (Slightly), Methanol (Slightly)
Appearance White to off-white solid or powder
Application Antiviral Agents
Storage Store at 2-8°C
Complexity 418
Exact Mass 371.96185
Index Of Refraction 1.685
In Vitro Previous in-vitro data showed that 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil (FEAU) had activity against herpes simplex virus types 1 and 2 comparable to that of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyluracil (FMAU), fialuridine (FIAU), and acyclovir (ACV). The cellular toxicity of FEAU was found to be much lower than that of FIAU. Biochemical experiments indicated that FEAU had similar affinity toward thymidine kinases encoded by HSV 1 and 2 and a much lower affinity for cellular thymidine kinase than thymidine.
In Vivo The in-vivo antiviral efficiency of FEAU was compared with that of FIAU and ACV by using the herpes encephalitis mode. Moreover, ACV and FEAU could significantly increase the number of survivors at doses of 50 and 100 mg/kg per day, respectively, and FIAU showed significant activity at 25 mg/kg per day in the animal model.
PSA 104.55000
Target DNA/RNA Synthesis; Orthopoxvirus
XLogP3-AA -0.9

TAKE YOUR NEXT STEPS

Get Started With Our Industry Experience And Client-Centric Focus!

Talk to Us

Copyright © 2024 BOC Sciences. All rights reserved.